Compare Okta, Inc. (OKTA) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Okta, Inc. vs Tenet Healthcare Corporation — how do they compare? Okta, Inc. trades at $221.23 (market cap $38.11B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Okta, Inc. is the larger of the two by market cap, and Okta, Inc. is trading nearer its 52-week high, Tenet Healthcare Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Okta, Inc. for 44 Days and Tenet Healthcare Corporation for 15 Days on average.
| OKTA | THC | |
|---|---|---|
Market Cap | $38.11B | $20.92B |
Volume | 2,259,293 | 455,764 |
Sector | Technology | Health |
52-Week High | $220.21 | $280.77 |
52-Week Low | $62.93 | $161.37 |
Typical Hold Time | 44 Days | 15 Days |
Enterprise Value | $35.86B | $32.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OKTA trades at $220.21, up 0.7% with strong technical momentum and bullish moving averages. The company shows improving fundamentals with revenue growth from $2.3B to $2.6B and a return to profitability in 2025. Recent earnings beats and positive analyst sentiment (73.6% buy ratings) support the bullish case, though high valuation multiples and insider selling present cautionary notes.
Outlook remains positive with AI security initiatives driving growth potential, but investors face valuation risks at current levels. The stock trades above consensus price target, suggesting limited near-term upside despite strong operational improvements and market positioning in the cybersecurity sector.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Okta, Inc.
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
Read more on OKTA →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
